BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9933608)

  • 1. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover.
    Silver DL; Jiang XC; Tall AR
    J Biol Chem; 1999 Feb; 274(7):4140-6. PubMed ID: 9933608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I.
    Gruen ML; Plummer MR; Zhang W; Posey KA; Linton MF; Fazio S; Hasty AH
    J Lipid Res; 2005 Sep; 46(9):2007-14. PubMed ID: 15995171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake.
    Silver DL; Wang N; Tall AR
    J Clin Invest; 2000 Jan; 105(2):151-9. PubMed ID: 10642593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
    Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
    J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes.
    Plump AS; Azrolan N; Odaka H; Wu L; Jiang X; Tall A; Eisenberg S; Breslow JL
    J Lipid Res; 1997 May; 38(5):1033-47. PubMed ID: 9186920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice.
    Hedrick CC; Castellani LW; Warden CH; Puppione DL; Lusis AJ
    J Biol Chem; 1993 Sep; 268(27):20676-82. PubMed ID: 8376417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver.
    Liang CP; Tall AR
    J Biol Chem; 2001 Dec; 276(52):49066-76. PubMed ID: 11551957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol 7alpha-hydroxylase influences the expression of hepatic apoA-I in two inbred mouse strains displaying different susceptibilities to atherosclerosis and in hepatoma cells.
    Dueland S; France D; Wang SL; Trawick JD; Davis RA
    J Lipid Res; 1997 Jul; 38(7):1445-53. PubMed ID: 9254069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
    Chan DC; Barrett PH; Ooi EM; Ji J; Chan DT; Watts GF
    J Clin Endocrinol Metab; 2009 Mar; 94(3):989-97. PubMed ID: 19116237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of HDL deficiency in mice overexpressing human apoA-II.
    Julve J; Escolà-Gil JC; Ribas V; González-Sastre F; Ordóñez-Llanos J; Sánchez-Quesada JL; Blanco-Vaca F
    J Lipid Res; 2002 Oct; 43(10):1734-42. PubMed ID: 12364558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein A-II modulates the binding and selective lipid uptake of reconstituted high density lipoprotein by scavenger receptor BI.
    de Beer MC; Durbin DM; Cai L; Mirocha N; Jonas A; Webb NR; de Beer FC; van Der Westhuyzen DR
    J Biol Chem; 2001 May; 276(19):15832-9. PubMed ID: 11279034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
    Srivastava RA; Srivastava N; Averna M
    Eur J Biochem; 2000 Jul; 267(13):4272-80. PubMed ID: 10866832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone stimulates apolipoprotein A-I production without affecting HDL removal in HepG2 cells: involvement of PPAR-alpha.
    Qin S; Liu T; Kamanna VS; Kashyap ML
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2428-34. PubMed ID: 17872455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.
    Brinton EA; Eisenberg S; Breslow JL
    Arterioscler Thromb; 1994 May; 14(5):707-20. PubMed ID: 8172849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism.
    de Beer MC; van der Westhuyzen DR; Whitaker NL; Webb NR; de Beer FC
    J Lipid Res; 2005 Oct; 46(10):2143-50. PubMed ID: 16061955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions.
    Hedrick CC; Castellani LW; Wong H; Lusis AJ
    J Lipid Res; 2001 Apr; 42(4):563-70. PubMed ID: 11290828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptors and lipid transfer proteins in HDL metabolism.
    Silver DL; Jiang XC; Arai T; Bruce C; Tall AR
    Ann N Y Acad Sci; 2000 May; 902():103-11; discussion 111-2. PubMed ID: 10865830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism.
    Hedrick CC; Hassan K; Hough GP; Yoo JH; Simzar S; Quinto CR; Kim SM; Dooley A; Langi S; Hama SY; Navab M; Witztum JL; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1946-52. PubMed ID: 10938016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.